Specific Activity Normal Polymorphisms Are Associated With High or Low Factor XIII Genotype/Phenotype Correlations for Coagulation Factor XIII: Specific

http://bloodjournal.hematologylibrary.org/content/93/3/897.full.html Updated information and services can be found at: (2497 articles) Hemostasis, Thrombosis, and Vascular Biology • Articles on similar topics can be found in the following Blood collections http://bloodjournal.hematologylibrary.org/site/misc/rights.xhtml#repub_requests Information about reproducing this article in parts or in its entirety may be found online at: http://bloodjournal.hematologylibrary.org/site/misc/rights.xhtml#reprints Information about ordering reprints may be found online at: http://bloodjournal.hematologylibrary.org/site/subscriptions/index.xhtml Information about subscriptions and ASH membership may be found online at:

[1]  R. Suzuki,et al.  Dynamics of blood coagulation factor XIII in ulcerative colitis and preliminary study of the factor XIII concentrate , 1989, Blut.

[2]  P. Board,et al.  The Val34Leu polymorphism in the A subunit of coagulation factor XIII contributes to the large normal range in activity and demonstrates that the activation peptide plays a role in catalytic activity. , 1998, Blood.

[3]  A. Markham,et al.  New Splicing Mutations in the Human Factor XIIIA Gene, Each Producing Multiple Mutant Transcripts of Varying Abundance , 1998, Thrombosis and Haemostasis.

[4]  A. Carter,et al.  Association of a Common Polymorphism in the Factor XIII Gene with Myocardial Infarction , 1998, Thrombosis and Haemostasis.

[5]  A. Markham,et al.  Identification of a large deletion, spanning exons 4 to 11 of the human factor XIIIA gene, in a factor XIII-deficient family. , 1998, Blood.

[6]  D. Schuppan,et al.  Identification of tissue transglutaminase as the autoantigen of celiac disease , 1997, Nature Medicine.

[7]  R. Powers,et al.  Transglutaminase activity is increased in Alzheimer's disease brain , 1997, Brain Research.

[8]  P. Reitsma,et al.  A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. , 1996, Blood.

[9]  L. Henke,et al.  Novel polymorphisms and haplotypes in the human coagulation factor XIII A-subunit gene , 1996, Human Genetics.

[10]  M. Pinotti,et al.  Factor VII gene polymorphisms contribute about one third of the factor VII level variation in plasma. , 1996, Arteriosclerosis, thrombosis, and vascular biology.

[11]  L. Iacoviello,et al.  Detection of New Polymorphic Markers in the Factor V Gene: Association with Factor V Levels in Plasma , 1996, Thrombosis and Haemostasis.

[12]  A. Stewart,et al.  Molecular basis of inherited factor XIII deficiency: identification of multiple mutations provides insights into protein function , 1995, British journal of haematology.

[13]  Y. Song,et al.  A microtiter assay for factor XIII using fibrinogen and biotinylcadaverine as substrates. , 1994, Analytical biochemistry.

[14]  L. Pedersen,et al.  Three-dimensional structure of a transglutaminase: human blood coagulation factor XIII. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[15]  K. Fickenscher,et al.  Determination of factor XIII activity by a new photometric assay in plasma and platelets of healthy blood donors. , 1994, Thrombosis research.

[16]  M. Paulsson,et al.  Transglutaminases: Protein Cross-Linking Enzymes in Tissues and Body Fluids , 1994, Thrombosis and Haemostasis.

[17]  C. Peters,et al.  Coagulation Factor XIII in Plasma of Patients with Benign and Malignant Gynaecological Tumours , 1994, European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies.

[18]  A. Evans,et al.  Genetic variation at the beta-fibrinogen locus in relation to plasma fibrinogen concentrations and risk of myocardial infarction. The ECTIM Study. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

[19]  K. Achyuthan,et al.  A microtiter plate transglutaminase assay utilizing 5-(biotinamido)pentylamine as substrate. , 1992, Analytical biochemistry.

[20]  A. Chitolie,et al.  Development and evaluation of ELISAs for factor XIIIA and XIIIB subunits in plasma. , 1992, Thrombosis research.

[21]  V. Chang,et al.  Lipoprotein (a) is a substrate for factor XIIIa and tissue transglutaminase. , 1991, The Journal of biological chemistry.

[22]  B. Nusgens,et al.  Factor XIII of blood coagulation decreases the susceptibility of collagen precursors to proteolysis. , 1991, Biochimica et biophysica acta.

[23]  A. Henney,et al.  Genetic variation at the plasminogen activator inhibitor-1 locus is associated with altered levels of plasma plasminogen activator inhibitor-1 activity. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.

[24]  D. Mosher,et al.  Factor XIIIa-mediated cross-linking of fibronectin in fibroblast cell layers. Cross-linking of cellular and plasma fibronectin and of amino-terminal fibronectin fragments. , 1989, The Journal of biological chemistry.

[25]  T. L. Moser,et al.  Vitronectin is a substrate for transglutaminases. , 1988, Biochemical and biophysical research communications.

[26]  B. Gårdlund,et al.  Hemostasis in Crohn's disease: low factor XIII levels in active disease. , 1988, Scandinavian journal of gastroenterology.

[27]  K. N. Lee,et al.  Colorimetric assay of blood coagulation factor XIII in plasma. , 1988, Clinical chemistry.

[28]  C. Francis,et al.  Rapid Formation of Large Molecular Weight a-Polymers in Cross-Linked Fibrin Induced by High Factor XIII Concentrations , 1987 .

[29]  L. Fésüs,et al.  Kinetic determination of blood coagulation Factor XIII in plasma. , 1985, Clinical chemistry.

[30]  L. Lorand,et al.  Human factor XIII: fibrin-stabilizing factor. , 1980, Progress in hemostasis and thrombosis.

[31]  R. Doolittle,et al.  Amino acid sequence studies on factor XIII and the peptide released during its activation by thrombin. , 1974, Biochemistry.

[32]  S. Pizzo,et al.  Human Factor XIII from plasma and platelets. Molecular weights, subunit structures, proteolytic activation, and cross-linking of fibrinogen and fibrin. , 1973, The Journal of biological chemistry.

[33]  F. Duckert,et al.  A Hitherto Undescribed Congenital Haemorrhagic Diathesis Probably Due to Fibrin Stabilizing Factor Deficiency , 1961, Thrombosis and Haemostasis.

[34]  L. Lorand,et al.  On the Solubility of Fibrin Clots. , 1948, Science.